Showing results (841-850 of 1,564) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|June 21, 2013
Oxidative stress in oncohematologic diseases: an updateSelene Imbesi, Caterina Musolino, Alessandro Allegra, et al.Expert Review of Hematology|November 18, 2017
The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expressionPegah Adelvand, Mohammed Hamid, Soroush SardariExpert Review of Hematology|March 29, 2018
Checkpoint inhibitors and acute myelogenous leukemia: promises and challengesMansour Alfayez, Gautam BorthakurExpert Review of Hematology|March 22, 2018
Potential of BCL2 as a target for chronic lymphocytic leukemia treatmentRiccardo Moia, Fary Diop, Chiara Favini, et al.Expert Review of Hematology|December 22, 2018
Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemiaMassimo Breccia, Robin FoàExpert Review of Hematology|December 28, 2017
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic LeukemiaFranco Locatelli, Mattia Algeri, Pietro Merli, et al.Expert Review of Hematology|December 21, 2017
A contemporary look at FVIII inhibitor development: still a great influence on the evolution of hemophilia therapiesElena Santagostino, Guy Young, Manuel Carcao, et al.Expert Review of Hematology|January 31, 2019
Risk adapted post-transplant maintenance in multiple myelomaIuliana Vaxman, Morie GertzExpert Review of Hematology|March 9, 2018
Beyond JAK-2: potential targets for myeloproliferative neoplasm therapyPatrick M Harrington, Claire N HarrisonExpert Review of Hematology|July 2, 2016
A close insight to factor VIII inhibitor in the congenital hemophilia AShamsoreza Tabriznia-Tabrizi, Marzie Gholampour, Hassan MansouritorghabehPageof 157